Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis Surgery
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 90 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 1 Jan 2028
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Dexamethasone (0.1 mg/kg)
- Dexamethasone (0.2 mg/kg)
- Placebo
- Record updated
- 22 October 2026
Who can take part
- Age
- 10 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age 10 to 18 years
- Diagnosis of idiopathic scoliosis
- Scheduled for elective surgical correction of scoliosis under general anesthesia with bilateral ultrasound-guided erector spinae plane (ESP) blocks
- American Society of Anesthesiologists (ASA) physical status I-III
- Written informed consent provided by a parent or legal guardian
- Participant assent obtained when developmentally appropriate and in accordance with applicable ethical requirements
Who cannot take part
- Systemic corticosteroid therapy before surgery that, in the investigator's judgment, could affect study outcomes
- Chronic opioid therapy before surgery
- Chronic pain requiring regular analgesic medication
- Previous adverse reaction or clinically significant intolerance to fentanyl
- Known allergy or hypersensitivity to dexamethasone, local anesthetics, fentanyl, or other medications used in the study protocol
- Contraindication to ESP block, including infection at the planned injection site or clinically significant coagulation disorder
- Severe hepatic or renal impairment
- Any medical condition that, in the investigator's judgment, could interfere with study procedures, assessment of outcomes, or participant safety
- Diabetes mellitus or another clinically significant disorder of glucose metabolism
- Participation in another interventional clinical trial that could affect the study outcomes
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 10 and 18 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized, double-blind, placebo-controlled study will evaluate the effect of intravenous dexamethasone on postoperative analgesia in children and adolescents undergoing surgery for idiopathic scoliosis with bilateral erector spinae plane (ESP) blocks.
Read full original descriptionShow less
Participants will be randomly assigned in a 1:1:1 ratio to receive intravenous placebo, dexamethasone 0.1 mg/kg, or dexamethasone 0.2 mg/kg. All participants will receive standardized general anesthesia, bilateral ultrasound-guided ESP blocks, and multimodal postoperative analgesia.
The study will evaluate postoperative opioid requirements and the duration and quality of postoperative analgesia. Secondary outcomes will include postoperative pain intensity, time to first rescue opioid administration, the proportion of participants requiring rescue opioid analgesia, postoperative nausea and vomiting, blood glucose concentrations, and adverse events.
The study aims to determine whether intravenous dexamethasone improves postoperative analgesia following ESP block and whether the analgesic effect differs between the two studied dexamethasone doses.
The 3 groups in the trial
- PlaceboPlacebo, for comparison
Participants will receive intravenous placebo (0.9% sodium chloride) in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.
- Dexamethasone 0.1 mg/kgTreatment being tested
Participants will receive intravenous dexamethasone 0.1 mg/kg, with a maximum dose of 4 mg, in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.
- Dexamethasone 0.2 mg/kgTreatment being tested
Participants will receive intravenous dexamethasone 0.2 mg/kg, with a maximum dose of 8 mg, in addition to standardized general anesthesia, bilateral ultrasound-guided erector spinae plane (ESP) blocks, and standardized multimodal postoperative analgesia.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Two Doses of Intravenous Dexamethasone on Postoperative Analgesia After Erector Spinae Plane Block in Children Undergoing Surgery for Idiopathic Scoliosis: A Randomized, Double-Blind, Placebo-Controlled Trial
- Criteria questions
- Built from NCT07890220, who can take part
- Record updated
- 22 October 2026